VistaGen Therapeutics Competitors and Similar CompaniesClear all
VistaGen Therapeutics's competitors and similar companies include Tiaki Therapeutics, Newron Pharmaceuticals, EncepHeal Therapeutics and Acumen Pharma.
 VistaGen Therapeutics VistaGen Therapeutics is a biopharmaceutical company that develops and commercializes intranasal products. |  Tiaki Therapeutics Tiaki Therapeutics is a company developing therapeutics that target microglia, the immune cells of the brain, to address inflammatory-driven CNS disorders and protect cognitive function. |  Newron Pharmaceuticals Newron Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of drugs for the treatment of central nervous system disorders and pain. |  EncepHeal Therapeutics EncepHeal Therapeutics is a company that develops therapies for cocaine and methamphetamine addictions. |  Acumen Pharma Acumen Pharmaceuticals is a biopharmaceutical company that develops therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. | |
Founding Date | Founding Date 1998 | Founding Date 2017 | Founding Date 1999 | Founding Date 2014 | Founding Date 1996 |
Type | Type Public | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations South San Francisco, US HQ | Locations Cambridge, US HQ | Locations Milano, IT HQ Bresso, IT Stockholm, SE Zürich, CH Morristown, US | Locations Winston-Salem, US HQ Winston Salem, US | Locations Charlottesville, US HQ Carmel, US |
Employees | Employees 9 | Employees 1 | Employees 22 | Employees 1 | Employees 756% decrease |
Valuation ($) | Valuation ($) 82.5 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 174.5 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $486k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) €19.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($51.4m) (FY, 2025) | Net income N/A | Net income (€13.2m) (FY, 2025) | Net income N/A | Net income ($121.3m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 10m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 150k | Total funding raised $ 2.2m |
For sources of this data, please see the company profile
View Company Profiles
Tiaki Therapeutics
HQ
Cambridge, US
Employees
1
Tiaki Therapeutics is a company developing therapeutics that target microglia, the immune cells of the brain, to address inflammatory-driven CNS disorders and protect cognitive function.
View companyNewron Pharmaceuticals
HQ
Milano, IT
Employees
22
Newron Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of drugs for the treatment of central nervous system disorders and pain.
View companyEncepHeal Therapeutics
HQ
Winston-Salem, US
Employees
1
EncepHeal Therapeutics is a company that develops therapies for cocaine and methamphetamine addictions.
View companyAcumen Pharma
HQ
Charlottesville, US
Employees
7
Acumen Pharmaceuticals is a biopharmaceutical company that develops therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases.
View company